Biotech | August 11, 2021
Moderna to set up mRNA manufacturing in Canada
The collaboration will support Canada with direct access to rapid pandemic response capabilities
The collaboration will support Canada with direct access to rapid pandemic response capabilities
TSC causes epilepsy in up to 85 % of patients, and up to 60 % of those patients do not respond to standard anti-seizure medicines
Company working on COVID vaccine INO 4800
Preclinical and early human data indicate BriLife may confer enhanced immunity against Delta variant
Phase II trial will evaluate the safety and efficacy of ASC40 in patients with moderate to severe acne
Single booster dose at 6 months of NVX-CoV2373 increased wild-type neutralizing antibodies more than 4-fold versus primary vaccination series
Nexviazyme specifically targets the M6P receptor, the key pathway for enzyme replacement therapy, to effectively clear glycogen build-up in muscle cells
Advances deployment of mRNA technology across vaccines and therapeutics development
Whole-genome sequencing to identify genetic mutation; epidemiological studies to help assess the distribution and mathematical modelling to forecast spread
AstraZeneca, Sinopharm and Moderna were part of the study
Subscribe To Our Newsletter & Stay Updated
